Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFERASIROX vs DEFLAZACORT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFERASIROX vs DEFLAZACORT: Safety Overview

Metric DEFERASIROX DEFLAZACORT
Total FAERS Reports 11,322 3,831
Deaths Reported 2,661 149
Death Rate 23.5% 3.9%
Hospitalizations 4,008 592
Average Patient Age 49.8 yrs 25.7 yrs
% Female Patients 50.1% 15.1%
FDA Approval Date Apr 11, 2025 Apr 25, 2024
Manufacturer AvKARE Cranbury Pharmaceuticals, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription